A carregar...
Pimavanserin (Nuplazid™) for the treatment of Parkinson disease psychosis: A review of the literature
INTRODUCTION: Pimavanserin (Nuplazid™) is an atypical antipsychotic currently indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis. The antipsychotic effects of this new agent are believed to occur via selective inverse agonist activity at serotonin...
Na minha lista:
| Publicado no: | Ment Health Clin |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007714/ https://ncbi.nlm.nih.gov/pubmed/29955528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.09.230 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|